In addition to the Drug Resistance Mutations Chart, the IAS–USA has many resources related to HIV drug-resistant mutations.
Recent Webinars
The 2025 Update of the Drug Resistance Mutations in HIV-1: Review and Clinical Applications
Presenter: Annemarie M. Wensing, MD, PhD
Moderator: Douglas D. Richman, MD
Panelists: Roger Paredes, MD, PhD, Robert W. Shafer, MD, Francesca Ceccherini Silberstein, PhD
March 26, 2025
10:00 AM – 11:30 AM PT
March 26, 2025
10:00 AM – 11:30 AM PT
Basic Principles and Clinical Relevance of the IAS–USA 2022 Update of the Drug Resistance Mutations in HIV-1
Moderator: Douglas D. Richman, MD
January 31, 2024
January 31, 2024
9:00 AM – 10:30 AM PT
Basics of HIV Drug Resistance Mutations
December 14, 2022
10:00 AM – 11:30 AM
10:00 AM – 11:30 AM
HIV Drug Resistance: The 4th Decade
Presenter: Douglas D. Richman, MD
December 8, 2020
11:00 AM – 12:15 PM
11:00 AM – 12:15 PM
Journal Articles
- Current Evidence on Islatravir Drug Resistance and Implications for Future HIV Treatment
- Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistances – Recommendations from IAS–USA panels
- Resistance Testing Guidelines – Recommendations from IAS–USA panels
- HIV-1 Drug Resistance Mutations Figures and User Notes – Recommendations from the IAS–USA Drug Resistance Mutations Group